84 results
8-K
BTAX
Biostax Corp.
13 Sep 23
Departure of Directors or Certain Officers
5:16pm
”), Ms. Griffin agreed to provide a minimum of 40 hours of service to the Company per week as an independent consultant in connection with her duties
PRE 14C
jd104e
16 Dec 22
Preliminary information
4:31pm
8-K
EX-10.2
90at 84yy
9 Nov 22
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-10.1
4k86ha mn2tciqkt29
9 Nov 22
Entry into a Material Definitive Agreement
5:00pm
8-K
hihj jy8eiwjum
9 Nov 22
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-10.1
cor vk4s7o
12 Oct 22
Entry into a Material Definitive Agreement
8:49am
8-K
3q18nk5w
22 Jul 22
Immune Therapeutics, Inc. Appoints Dr. Stephen Wilson as Chief Executive Officer
3:44pm
8-K
EX-10.1
9ib0trn
22 Jul 22
Immune Therapeutics, Inc. Appoints Dr. Stephen Wilson as Chief Executive Officer
3:44pm
8-K
EX-99.1
a9b0g7om
22 Oct 20
Immune Therapeutics, Inc. Announces Signing of Definitive Merger Agreement Between Cytocom and Cleveland BioLabs
4:33pm